Generic Oncology Drug Manufacturing Plant Project Report: Industry Trends, Manufacturing Process, Machinery, Raw Materials, Cost and Revenue

  • ID: 3503789
  • Report
  • 69 pages
  • IMARC Group
1 of 3
Driven by rising cancer incidences, patent expiry of a number of blockbuster oncology drugs and the high cost of cancer treatment, the market for generic oncology drugs has been witnessing robust growth. Apart from their strong growth, these drugs also enjoy high product differentiation and entry barriers. As a result, competitive intensity in this segment is also relatively low. This has enabled manufacturer to enjoy higher pricing power and margins compared to commoditised generics.

Our latest study “Generic Oncology Drug Manufacturing Plant Project Report: Industry Trends, Manufacturing Process, Machinery, Raw Materials, Cost and Revenue” provides a comprehensive roadmap for stakeholders who are planning to setup and run a generic drug manufacturing plant. Aspects such as market size, industry trends, manufacturers, land, construction, machinery, labour, investments, revenues, rate of return, margins, etc. have been thoroughly covered in this report

Key Questions Answered in This Report?

What are the historical, current and future trends in the generic market?
What are the historical, current and future trends in the generic oncology market?
What is the competitive structure of the generic market and who are the key players?
What is the competitive structure of the generic oncology market and who are the key players?
What are the key success factors for generic oncology drug manufacturers?
How are generic oncology drugs manufactured?
What are the raw material requirements and their cost for manufacturing generic oncology drugs?
What are the land and construction requirements and their cost for manufacturing generic oncology drugs?
What are the machinery requirements and their cost for manufacturing generic oncology drugs?
What are the packaging requirements and their cost for manufacturing generic oncology drugs?
What are the utility requirements and their cost for manufacturing generic oncology drugs?
What are the manpower requirements and their cost for manufacturing generic oncology drugs?
What is the total capital investment required for setting up a generic oncology drug manufacturing plant
What are the operational costs for setting up a generic oncology drug manufacturing plant?
How much income will the generic oncology drug manufacturing plant generate?
What will be the profitability of the generic oncology drug manufacturing plant?
What will be the NPV of the generic oncology drug manufacturing plant?
What will be the payback period of the generic oncology drug manufacturing plant?
READ MORE
Note: Product cover images may vary from those shown
2 of 3
"1 Research Methodology
2 Report Summary
3 Introduction
4 Global Generic Drug Market
4.1 Classification of Generic Drugs
4.2 Market Trends
4.2.1 Current and Historical Market Trends
4.2.2 Market Breakup by Region
4.2.3 Major Players in the Generic Drug Industry
4.2.4 Market Forecast
4.3 Value Chain Analysis of Generic Drugs
4.4 Key Success Factors Driving the Generic Drug Industry
4.6 Regulations in the Generic Drug Industry
5 Global Cancer Generics Market
5.1 Global Cancer Statistics
5.2 Current and Historical Market Trends
5.3 Top Cancer Drugs
5.4 Top Players in the Cancer Generics Market
5.5 Market Forecast
6 Manufacturing Process
6.1 Detailed Process Flow (Tablet)
6.2 Detailed Process Flow (Injectables)
6.3 Cancer Generic Manufacturing Plant: Raw Material Requirements
6.3.1 Cancer Generic Drug (Tablet)
6.3.2 Cancer Generic Drug (Injectables)
7 Project Details, Requirements and Costs Involved
7.1 Land, Location and Site Development
7.2 Plant Machinery
7.3 Machinery Pictures
7.4 Raw Materials
7.5 Packaging
7.6 Utilities
7.7 Manpower
7.8 Other Capital Investments
8 Cancer Generic Drug Manufacturing Plant: Project Economics
8.1 Capital Cost of the Project
8.2 Loans and Financial Assistance
8.3 Techno-Economic Parameters
8.4 Product Pricing
8.5 Income Projections
8.6 Expenditure Projections
8.7 Financial Analysis

Figure 1 1: Global: Cancer Incidence: Breakup by Country (in %), 2014
Figure 4 1: Global: Generics Market: Sales Value (in US$ Billion), 2010-2014
Figure 4 2: Global: Generics Market: Breakup by Country (in %), 2014
Figure 4 3: Global: Generics Market: Sales Value (in US$ Billion), 2015-2020
Figure 4 4: Global: Generics Market: Value Chain
Figure 5 1: Global: Cancer Incidence: 2007-2014
Figure 5 2: Global: Cancer Incidence: Breakup by Country (in %), 2014
Figure 5 3: Global: Cancer GenericsMarket: Sales Value (in US$ Billion), 2007-2014
Figure 5 4: Global: Cancer Generics Market Forecast: Sales Value (in US$ Billion), 2015-2020
Figure 6 1: Cancer Generic (Tablet) Manufacturing: Detailed Process Flow
Figure 6 2: Cancer Generic (Injectable) Manufacturing: Detailed Process Flow
Figure 6 3: Cancer Generic (Imatinib Tablet) Manufacturing Process: Conversion Rate of Feedstocks
Figure 6 4: Cancer Generic (Paclitaxel) Manufacturing Process: Conversion Rate of Feedstocks
Figure 7 1: Cancer Generic Manufacturing Plant: Primary Packaging
Figure 7 2: Cancer Generic Manufacturing Plant: Secondary Packaging
Figure 7 3: Cancer Generic Manufacturing Plant: Tertiary Packaging
Figure 8 1: Cancer Generic Manufacturing Plant: Breakup of Capital Costs (in %)
Figure 8 2: Cancer Generic Manufacturing Plant: Breakup of Production Costs (in %)

Table 4 1: Global: Generics Market: Revenues of Key Players (in US$ Billion), 2014
Table 7 1: Cancer Generic Manufacturing Plant: Costs Related to Land and Site Development (in US$)
Table 7 2: Cancer Generic Manufacturing Plant: Costs Related to Civil Works (in US$)
Table 7 3: Cancer Generic Manufacturing Plant: Machinery Costs (in US$)
Table 7 4: Cancer Generic Manufacturing Plant: Raw Material Requirements (in Kg/Day)
Table 7 5: Cancer Generic Manufacturing Plant: Costs Related to Salaries and Wages (in US$)
Table 7 6: Cancer Generic Manufacturing Plant: Costs Related to Other Capital Investments (in US$)
Table 8 1: Cancer Generic Manufacturing Plant: Capital Costs (in US$)
Table 8 2: Details of Financial Assistance Offered by Financial Institutions
Table 8 3: Cancer Generic Manufacturing Plant: Loan Installments
Table 8 4: Cancer Generic Manufacturing Plant: Techno- Economic Parameters
Table 8 5: Cancer Generic Manufacturing Plant: Income Projections (in US$)
Table 8 6: Cancer Generic Manufacturing Plant: Expenditure Projections (in US$)
Table 8 7: Cancer Generic Manufacturing Plant: Cash Flow Analysis Without Considering the Income Tax Liability
Table 8 8: Cancer Generic Manufacturing Plant: Cash Flow Analysis on Considering the Income Tax Liability
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll